Literature DB >> 20201644

Lack of association between CYP21 V281L variant and polycystic ovary syndrome in Italian women.

Laura Pucci1, Daniela Lucchesi, Vincenzo Longo, Stefano Del Prato, Silvia Maffei.   

Abstract

AIM: To investigate the association between V281L CYP21 polymorphism and the hyperandrogenic phenotype of polycystic ovary syndrome (PCOS), in a cohort of 110 Italian women.
METHODS: The CYP21 genotype distribution was evaluated in 50 women with PCOS and 60 control subjects. Genotypes were detected using restriction fragment length polymorphism (RFLP) analysis performed on polymerase chain reaction templates from genomic DNA. Genotypes distribution was compared between groups and we considered a p-value less than 0.05 as statistically significant.
RESULTS: The frequency of VV, VL and LL was in agreement with other populations. Nevertheless no significant association was observed between CYP21 polymorphism and the presence of PCOS in an Italian cohort of women.
CONCLUSION: Although CYP21 gene, involved in steroidogenesis, is a candidate gene for pathogenesis of PCOS, our data suggest that V281L polymorphism is not associated with PCOS in Italian women; a larger study is needed to confirm this result.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20201644     DOI: 10.3109/09513591003649849

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  2 in total

Review 1.  An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options.

Authors:  Hiya Islam; Jaasia Masud; Yushe Nazrul Islam; Fahim Kabir Monjurul Haque
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

2.  Non-Classical Congenital Adrenal Hyperplasia-Causing Alleles in Adolescent Girls with PCOS and in Risk Group for PCOS Development.

Authors:  Lasma Lidaka; Laine Bekere; Gunta Lazdane; Iveta Dzivite-Krisane; Anda Kivite-Urtane; Linda Gailite
Journal:  Diagnostics (Basel)       Date:  2021-05-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.